Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Natural Products Withaferin A and Withanone from the Medicinal HerbWithania somniferaAre Covalent Inhibitors of the SARS-CoV-2 Main Protease
Shayantani Chakraborty, Dibyendu Mallick, Mausumi Goswami, et al.
Journal of Natural Products (2022) Vol. 85, Iss. 10, pp. 2340-2350
Closed Access | Times Cited: 23

Showing 23 citing articles:

The immunomodulatory role of withania somnifera (L.) dunal in inflammatory diseases
Hamad H. Alanazi, Elyasa Mustafa Elfaki
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 27
Structure-Based Discovery of the SARS-CoV-2 Main Protease Noncovalent Inhibitors from Traditional Chinese Medicine
Xiaojie Jin, Min Zhang, Beibei Fu, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 4, pp. 1319-1330
Closed Access | Times Cited: 7
Preclinical pharmacokinetics, absolute bioavailability and dose proportionality evaluation of bioactive phytochemical Withanone in rats
Sandeep Kumar Singh, Mamunur Rashid, Swati Chaturvedi, et al.
Bioorganic Chemistry (2025) Vol. 155, pp. 108128-108128
Open Access
Chemoproteomics reveals proteome-wide covalent and non-covalent targets of withaferin A
Hui-Jun Nie, Yingjie Fu, Shang Long, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
The aqueous root extract of Withania somnifera ameliorates LPS-induced inflammatory changes in the in vitro cell-based and mice models of inflammation
Phulwanti Kumari Sharma, Lokesh Kumar, Yamini Goswami, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 11
Covalent binding of withanolides to cysteines of protein targets
Christian Bailly
Biochemical Pharmacology (2024) Vol. 226, pp. 116405-116405
Open Access | Times Cited: 3
Progress in Research on Inhibitors Targeting SARS-CoV-2 Main Protease (Mpro)
Yue Yang, Yidan Luo, Chenbo Zhang, et al.
ACS Omega (2024) Vol. 9, Iss. 32, pp. 34196-34219
Open Access | Times Cited: 3
Phytochemicals of Withania somnifera as a Future Promising Drug against SARS-CoV-2: Pharmacological Role, Molecular Mechanism, Molecular Docking Evaluation, and Efficient Delivery
Suaidah Ramli, Yuan Seng Wu, Kalaivani Batumalaie, et al.
Microorganisms (2023) Vol. 11, Iss. 4, pp. 1000-1000
Open Access | Times Cited: 8
Advanced technologies for screening and identifying covalent inhibitors
Yaolin Guo, Shuai Wen, Aiping Tong, et al.
TrAC Trends in Analytical Chemistry (2024) Vol. 178, pp. 117833-117833
Closed Access | Times Cited: 2
Can Ashwagandha Benefit the Endocrine System?—A Review
Michał Wiciński, Anna Fajkiel-Madajczyk, Zuzanna Kurant, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16513-16513
Open Access | Times Cited: 7
Unraveling antiviral efficacy of multifunctional immunomodulatory triterpenoids against SARS‐COV‐2 targeting main protease and papain‐like protease
Shweta Choudhary, Sanketkumar Nehul, Ankur Singh, et al.
IUBMB Life (2023) Vol. 76, Iss. 5, pp. 228-241
Open Access | Times Cited: 7
Effective inhibition of HCoV-OC43 and SARS-CoV-2 by phytochemicals in vitro and in vivo
Durbadal Ojha, Forrest Jessop, Catharine M. Bosio, et al.
International Journal of Antimicrobial Agents (2023) Vol. 62, Iss. 3, pp. 106893-106893
Open Access | Times Cited: 5
Molecular networking unveils anti-SARS-CoV-2 constituents from traditionally used remedies
Andreas Wasilewicz, Denisa Bojková, Mehdi A. Beniddir, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117206-117206
Closed Access | Times Cited: 5
Review from host and guest approach to new frontiers nutraceuticals in the era of COVID-19
Matteo Micucci, Silvia Gioacchini, Melissa Baggieri, et al.
Future Foods (2024) Vol. 9, pp. 100303-100303
Open Access | Times Cited: 1
Divergent synthesis of complex withanolides enabled by a scalable route and late-stage functionalization
Wen Che, Lukasz Wojitas, Chuan Shan, et al.
Science Advances (2024) Vol. 10, Iss. 26
Open Access | Times Cited: 1
How many organic small molecules might be used to treat COVID-19? From natural products to synthetic agents
Zai‐Qun Liu
European Journal of Medicinal Chemistry (2024) Vol. 278, pp. 116788-116788
Closed Access | Times Cited: 1
Unlocking the potential of phytochemicals in inhibiting SARS-CoV-2 M Pro protein - An in-silico and cell-based approach
Khushboo Singh, J. J. Patten, Andrea Dimet‐Wiley, et al.
Research Square (Research Square) (2024)
Open Access
Antileishmanial, antitrypanosomal and anti-coronavirus activities of benzophenanthridine alkaloids and other specialized metabolites isolated from the root bark of Zanthoxylum zanthoxyloides (Lam.) B.Zepernick & Timler
Abda Ba, Vincent Roumy, Malak Al Ibrahim, et al.
Fitoterapia (2024) Vol. 179, pp. 106232-106232
Closed Access
Withaferin A inhibits Chikungunya virus nsP2 protease and shows antiviral activity in the cell culture and mouse model of virus infection
Kiran Bala Sharma, Chandru Subramani, Ganesh Kondabattula, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 12, pp. e1012816-e1012816
Open Access
Unraveling antiviral efficacy of multifunctional immunomodulatory triterpenoids against SARS-COV-2 targeting main protease and papain-like protease
Shweta Choudhary, Sanketkumar Nehul, Ankur Singh, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Divergent synthesis of complex withanolides enabled by a scalable route and late-stage functionalization.
Wen Che, Lukasz Wojitas, Chuan Shan, et al.
(2023)
Open Access | Times Cited: 1
Withaferin A Inhibits Liver Cancer Tumorigenesis by Suppressing Aerobic Glycolysis through the p53/IDH1/HIF-1α Signaling Axis
Xiangyang Zhou, Di Wu, Linmiao Zhu, et al.
Current Cancer Drug Targets (2023) Vol. 24, Iss. 5, pp. 534-545
Closed Access
Page 1

Scroll to top